Impact of Dapagliflozin on the Left Ventricular Diastolic Function in Diabetic Patients with Heart Failure Complicating Cardiovascular Risk Factors-Reference-Cited by-同舟云学术

Impact of Dapagliflozin on the Left Ventricular Diastolic Function in Diabetic Patients with Heart Failure Complicating Cardiovascular Risk Factors

Published:2021-08-01 Issue:15 Volume:60 Page:2367-2374
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Soga Fumitaka¹,Tanaka Hidekazu¹,Tatsumi Kazuhiro¹,Mochizuki Yasuhide²,Sano Hiroyuki³,Toki Hiromi⁴,Matsumoto Kensuke¹,Shite Junya²,Takaoka Hideyuki³,Doi Tomofumi⁴,Hirata Ken-ichi¹

Affiliation:

1. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan

2. Division of Cardiology, Osaka Saiseikai Nakatsu Hospital, Japan

3. Division of Cardiology, Aijinkai Takatsuki Hospital, Japan

4. Division of Cardiology, Kobe Red Cross Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/15/60_6127-20/_pdf

Reference26 articles.

1. 1. Vaur L, Gueret P, Lievre M, Chabaud S, Passa P; study DSG. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. Diabetes Care 26: 855-860, 2003.

2. 2. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 103: 2668-2673, 2001.

3. 3. Vazquez-Benitez G, Desai JR, Xu S, et al. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care 38: 905-912, 2015.

4. 4. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038, 1979.

5. 5. Writing Committee Members, Yancy CW, Jessup M, et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134: e282-e293, 2016.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes: A sub-analysis of the PROTECT trial;J CARDIOL;2024

2. Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes: A sub-analysis of the PROTECT trial;Journal of Cardiology;2024-10

3. The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects;Kardiologiia;2024-07-31

4. Is early use of SGLT2i necessary even in patients with cardiovascular risk factors? : A prospective study regarding the effect of SGLT2i on left ventricular diastolic function;2024-07-29

5. Influence of dapagliflozin on cardiovascular remodeling in hypertensive patients with accompanying type 2 diabetes;Pathologia;2024-04-22